Peptide education,
honestly built.
The Peptide Column is written and reviewed by practicing clinicians. We exist because the peptide space is flooded with marketing dressed up as medicine — and patients deserve better.
Physician Assistant (PA-C)
Board-certified PA practicing in family medicine with clinical expertise in peptide therapy, hormone replacement therapy, GLP-1 agonists, and metabolic medicine. Over a decade of patient care informing every profile.
Clinical review panel
All content is reviewed by licensed MDs, DOs, PAs, and NPs acting in an editorial capacity. Reviewers hold active clinical licenses and maintain continuing education in their specialties.
Patients deserve better.
The peptide space is flooded with content written by marketers, supplement companies, and influencers with undisclosed financial relationships. Patients searching for real answers about BPC-157 (a Category 2 substance — not FDA-approved, with compounding prohibited under current FDA interim policy), semaglutide, and dozens of others are met with exaggerated claims, cherry-picked studies, and thinly veiled sales pitches.
We built The Peptide Column because patients deserve evidence-based information — not marketing hype.
Four promises, publicly checkable.
12-point bias screen
Every study we cite is screened for industry funding, small samples, spin, and nine other common sources of bias in medical research.
Questions for your doctor
Every profile ends with specific questions to bring to your provider. We help you have better conversations — we don't replace them.
22 global research sources
PubMed and ClinicalTrials.gov plus repositories in Russia, Israel, Japan, and South America that most English-language sites ignore.
No vendor money
We don't sell peptides. We don't take money from peptide vendors. Revenue is from newsletter ads, disclosed affiliates, and products.
How we work, in five sentences.
- 01 Content is written and reviewed by MDs, DOs, PAs, and NPs with active clinical licenses.
- 02 Commercial relationships never influence editorial content.
- 03 We disclose where evidence is weak, where gaps exist, and what questions remain unanswered.
- 04 Every profile includes an honest evidence rating: Strong / Emerging / Theoretical / No Human Data.
- 05 Affiliate relationships are disclosed per FTC guidelines on our Affiliate Disclosure page.
One careful letter every Sunday.
A single research question, unpacked honestly. No hype, no vendor pitches.
Subscribe free